Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA
about
Cloning of the human uroplakin 1B cDNA and analysis of its expression in urothelial-tumor cell lines and bladder-carcinoma tissueEWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamilyTetraspanin protein CD9 interacts with metalloprotease CD10 and enhances its release via exosomesSelective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactionsTargeting serous epithelial ovarian cancer with designer zinc finger transcription factorsDHHC2 affects palmitoylation, stability, and functions of tetraspanins CD9 and CD151Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenanceImportance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activityIntegrins as receptors for lamininsSpecific association of CD63 with the VLA-3 and VLA-6 integrinsIdentification of a novel structural variant of the alpha 6 integrinThe gamete fusion process is defective in eggs of Cd9-deficient miceAssociation between the rat homologue of CO-029, a metastasis-associated tetraspanin molecule and consumption coagulopathyGene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators.Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients.CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells.Increased density of retinal pigment epithelium in cd81-/- miceAn imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.Effect of an anti-human Co-029/tspan8 mouse monoclonal antibody on tumor growth in a nude mouse model.Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization.Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.Lateral organization of membrane proteins: tetraspanins spin their web.Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma.Diminished metastasis in tetraspanin CD151-knockout mice.The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organizationExosomes released from breast cancer carcinomas stimulate cell movementRecurrent infectious diseases in human CD53 deficiency.Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinomaCorrelation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.Enkephalins stimulate leukemia cell migration and surface expression of CD9Expression and distribution of CD9 in myelin of the central and peripheral nervous systems.Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor bindingRole of tumor cell adhesion and migration in organ-specific metastasis formation.Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signalingTargeting of tetraspanin proteins--potential benefits and strategiesMembrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice.Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma.Clinical significance of transmembrane 4 superfamily in colon cancer.
P2860
Q22001476-0C5F052D-3100-4B46-ACB1-2EE96DCA38E9Q24291564-12C25491-F42D-403A-ACD4-0CC386682960Q24307698-BF51C5A2-58DC-4592-85EF-91E9C3F7490BQ24531490-B5189AFB-5155-4DB7-9A68-60A8A67E8AC1Q24605597-BC011D3E-BE7B-4187-9BA1-53041037631CQ24653644-B586F6B9-9A7D-47EE-8A64-CBF39950D10DQ24683519-D439828C-6225-4223-81E6-FF9722AC8D65Q28115248-21B6C945-67DF-43C9-9F6B-6BABEFEA25D6Q28142460-9E16574C-BB2B-44D3-B475-8DBD0110AC3AQ28294878-C7660A20-8A55-4F7B-B95D-34B85AEA7C0BQ28365460-600CF9C5-355F-44B8-BE83-3915F0B30808Q28505612-127E5EEE-FC4B-45C7-B3AD-6D038B464EEBQ28564140-97162123-10C5-4DAB-B5D0-092B8BFF339BQ30779002-A6F61B7B-AD95-4068-BAE8-C3E722BCC256Q33253492-B6E1C858-2C6F-46CA-B7EB-5E7E64D64A97Q33608299-16B056DD-3F07-445C-A273-50D653F925DDQ33652457-EB1371E4-1276-42FE-AD1A-58C6403BBE08Q33692066-E72738C1-D529-4AA7-BCEC-9A8709D0B610Q34211752-3FA3B609-A194-46CB-BD61-00D73A6881B8Q34502138-0253C359-CC0B-46F8-B040-A01B5E96A312Q34914039-2B8DA72D-484E-42A5-BAEB-879C43DA0282Q34979935-F98341E4-3AF8-466C-A931-948F5D57FE03Q35023643-F3BF3E65-1C10-4854-A7E1-C8B9CAFDF228Q35112273-F21A630F-2707-4CF3-9BF1-2FCC53CE8AE7Q35140877-578BD28A-93F6-465F-9B8D-9286B01E9FF1Q35208040-DB7BA2FE-F4BD-470C-A5BE-D0014BA73C7EQ35229281-E9113E76-05ED-4212-A1CD-F1AF11DFBD13Q35632281-0A60A05B-1117-45AD-AD07-8B5810DB68F4Q35753387-21A92568-1669-4E0D-97A1-149748B9C8A7Q35762895-4F133207-ADB5-41BD-A31C-4F943111EA07Q35782625-E2914FF0-294C-4ED7-844B-87EB29B0FD67Q35889361-FA9390D0-67E5-41C9-84D7-D49B2B85160EQ35980557-B466F685-5316-428D-A437-82751A3006A3Q36301561-01EF3EC0-41B6-4ACB-9D1E-0F02918C1351Q36533706-6989D321-4D86-4B98-8BEB-7F201CB081BFQ36535723-62B0AF66-D920-4463-A5F4-F60477728DA6Q36597251-00FEEC57-AADB-43C7-9D28-2D8177E5C1ACQ36617498-53076289-AE4F-4621-9F8F-C96B533B580EQ36642812-7D9A3275-FC61-41A5-89C6-FA2079788AD3Q36670743-483BED9C-B0A8-419D-BEB1-256BCA03BC91
P2860
Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@ast
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@en
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@en-gb
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@nl
type
label
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@ast
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@en
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@en-gb
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@nl
prefLabel
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@ast
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@en
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@en-gb
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@nl
P2093
P2860
P3181
P356
P1476
Suppression of cell motility a ...... elated protein (MRP-1/CD9) DNA
@en
P2093
P2860
P304
P3181
P356
10.1084/JEM.177.5.1231
P407
P577
1993-05-01T00:00:00Z